Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells
- 29 July 2010
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 323 (2), 239-245
- https://doi.org/10.1016/j.mce.2010.04.017
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer TumorsClinical Cancer Research, 2006
- In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate TumorsClinical Cancer Research, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- LuCaP 35: A new model of prostate cancer progression to androgen independenceThe Prostate, 2003
- Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland DevelopmentEndocrinology, 1999
- Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell lineThe Prostate, 1998
- The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus- 40 T antigenJournal of Clinical Endocrinology & Metabolism, 1996
- Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expressionInternational Journal of Cancer, 1994
- Endocrine Therapy for Prostate Cancer: Recent Developments and Current StatusBritish Journal of Urology, 1993
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990